Clinical Trial Update: A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant nivolumab + palbociclib + anastrozole in post-menopausal women and men with primary breast cancer has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Palbociclib (palbociclib)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Breast Cancer, Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-08-10